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trations of enzymes at 37 8C and the certification of reference
preparations. Other parts deal with: Part 1. The concept of
reference procedures for the measurement of catalytic activ-
ity concentrations of enzymes; Part 2. Reference procedure
for the measurement of catalytic concentration of creatine
kinase; Part 3. Reference procedure for the measurement of
catalytic concentration of lactate dehydrogenase; Part 4. Ref-
erence procedure for the measurement of catalytic concen-
tration of alanine aminotransferase; Part 5. Reference
procedure for the measurement of catalytic concentration of
aspartate aminotransferase; Part 6. Reference procedure for
the measurement of catalytic concentration of g-glutamyl-
transferase; Part 7. Certification of four reference materials
for the determination of enzymatic activity of g-glutamyl-
transferase, lactate dehydrogenase, alanine aminotransferase
and creatine kinase at 37 8C; Part 8. Reference procedure for
the measurement of catalytic concentration of a-amylase.
The procedure described here is derived from the previously
described 30 8C IFCC reference method. Differences are
tabulated and commented on in Appendix 1.
Keywords: alkaline phosphatase; IFCC reference procedure;
reference intervals.
Introduction
The catalytic concentration of alkaline phosphatase (ALP)
(Orthophosphoric-Monoester Phosphohydrolase, Alkaline
Optimum, EC 3.1.3.1) in serum represents the activity of
multiple forms of the enzyme. More than 17 isoforms of
ALP are detectable by use of an isoelectric focusing tech-
nique (1). The catalytic concentration of ALP in serum of
healthy adults originates from the liver and from bone in
similar proportions. ALP from the small intestine contributes
to approximately 10 % of total ALP in healthy individuals.
If not physiologically induced by growth of bone or in preg-
nancy, increase of ALP in serum occurs as a consequence of
disease of the liver and/or bone.
The determination of the catalytic concentration of ALP
in serum depends strongly on the chosen measurement para-
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Table 1 Concentrations in the final complete reaction mixture for
the measurement of ALP.
2-Amino-2-methyl-1-propanol 750 mmol/L
pH (37 8C) 10.20"0.05a
4-Nitrophenyl phosphate 16 mmol/L
Zinc sulfate 1 mmol/L
Magnesium acetate 2 mmol/L
HEDTA 2 mmol/L
Volume fraction of sample 0.0196 (1:51)
aMaximum allowable expanded uncertainty (95 % probability).
Table 2 Measurement conditions for the measurement of ALP.
Temperature 37.0 8C"0.1 8Ca
Wavelength 405 nm"1 nma
Band width F2 nm
Light path 10.00 mm"0.01 mma
Incubation time 60 s
Delay time 90 s
Measurement interval 120 s
Readings (measurement points) G6
aMaximum allowable expanded uncertainty (95 % probability).
meters. Among these, the choice of the buffer is of great
importance. In 1983 an expert group of the International Fed-
eration of Clinical Chemistry (IFCC) provided a proposal for
a standardized measurement procedure for ALP (2, 3). The
reaction principle was based on the use of 2-amino-2-methyl-
1-propanol (AMP) and 4-nitrophenyl phosphate (NPP); the
measurement temperature was 30 8C. Even though this pro-
cedure for ALP was never endorsed as official IFCC rec-
ommendation by the IFCC member societies, many
commercial test kits for ALP currently use the AMP buffer.
This paper describes the IFCC primary reference meas-
urement procedure for ALP, which is based on the previous
IFCC work (2, 3). The change of the measurement temper-
ature from 30 8C to 37 8C necessitated a re-evaluation of the
measurement conditions. The results of this re-evaluation
with very detailed definition of the measurement parameters
relevant for high-level standardization are described. This
paper is the ninth in a series dealing with reference proce-
dures for the measurement of catalytic activity concentra-
tions of enzymes at 37 8C and the certification of reference
preparations (4–11).
The reference measurement procedure for ALP will be of
use in a reference measurement system for the certification
of calibrators and control materials, thus providing the basis
to allow the clinical laboratories to produce traceable meas-
urement results and to establish definitive reference intervals
(12, 13). In particular, here we provide only preliminary ref-
erence intervals for adult subjects; ALP reference intervals
undergo important changes dependent on age and gender and
further work is needed to obtain the full range of reference
intervals.
Reaction principle
ALP catalyzes the hydrolysis of NPP, forming phosphate and
free 4-nitrophenol; under alkaline conditions, 4-nitrophenol
is converted to the 4-nitrophenoxide ion. AMP and H2O are
used as phosphate-acceptors:
ALP1) 4-Nitrophenyl phosphateqH O 4-Nitrophenoxide———)2
qPhosphate
ALP2) 4-Nitrophenyl phosphateqAMP 4-Nitrophenoxide———)
qAMP-Phosphate
Specimens
Calibration materials, control specimens and human sera.
Measurement conditions
Concentrations in the final reaction mixture and the meas-
urement conditions are listed in Tables 1 and 2.
: The compliances with the prescribed maximumNote
allowable expanded uncertainties (95 % probability) of the
values for temperature, pH, light path and wavelength are
confirmed if the expanded uncertainty of the calibration
(95 % probability) is equal to or smaller than the maximum
allowable expanded uncertainty, and the result of the cali-
bration does not differ significantly (pF0.05) from the target
value. This is valid if
value Ivaluetarget calibration F1Z Z2 2y(U HU )max cal
where valuetarget is the target value prescribed in the IFCC
document; valuecalibration is the result determined with the cali-
bration procedure; Umax is the maximum allowable expanded
uncertainty prescribed in the IFCC document; and Ucal is the
maximum expanded uncertainty of the result of the
calibration procedure.
Reagents
1. 2-Amino-2-methyl-1-propanol (C4H11NO), Mrs89.14
2. 4-Nitrophenyl phosphate, disodium salt, hexahydrate
(C6H4NNa2O6PØ6H2O), Mrs371.14
3. Magnesium acetate wMg(C2H3O2)2Ø4H2Ox, Mrs214.46
4. Zinc sulfate (ZnSO4Ø7H2O), Mrs287.54
5. N-(2-Hydroxyethyl)ethylenediamine-N,N9,N9-triacetic
acid (HEDTA), trisodium salt (C10H15N2Na3O7), Mrs
344.20 (anhydrous)
6. Hydrochloric acid (HCl), Mrs36.46, 25 %
7. Hydrochloric acid (HCl), Mrs36.46, 2 mol/L
8. Sodium chloride (NaCl), Mrs58.44
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15.00 10.906 23.50 10.619 32.00 10.352
15.25 10.897 23.75 10.611 32.25 10.344
15.50 10.889 24.00 10.603 32.50 10.337
15.75 10.880 24.25 10.595 32.75 10.329
16.00 10.871 24.50 10.587 33.00 10.321
16.25 10.862 24.75 10.579 33.25 10.314
16.50 10.854 25.00 10.571 33.50 10.306
16.75 10.845 25.25 10.563 33.75 10.298
17.00 10.836 25.50 10.555 34.00 10.291
17.25 10.828 25.75 10.547 34.25 10.283
17.50 10.819 26.00 10.539 34.50 10.276
17.75 10.811 26.25 10.531 34.75 10.268
18.00 10.802 26.50 10.523 35.00 10.260
18.25 10.794 26.75 10.515 35.25 10.253
18.50 10.785 27.00 10.507 35.50 10.245
18.75 10.777 27.25 10.500 35.75 10.238
19.00 10.768 27.50 10.492 36.00 10.230
19.25 10.760 27.75 10.484 36.25 10.223
19.50 10.751 28.00 10.476 36.50 10.215
19.75 10.743 28.25 10.468 36.75 10.208
20.00 10.735 28.50 10.460 37.00 10.200
20.25 10.726 28.75 10.453 37.25 10.192
20.50 10.718 29.00 10.445 37.50 10.185
20.75 10.710 29.25 10.437 37.75 10.177
21.00 10.701 29.50 10.429 38.00 10.170
21.25 10.693 29.75 10.421 38.25 10.162
21.50 10.685 30.00 10.414 38.50 10.155
21.75 10.677 30.25 10.406 38.75 10.147
22.00 10.668 30.50 10.398 39.00 10.140
22.25 10.660 30.75 10.390 39.25 10.132
22.50 10.652 31.00 10.383 39.50 10.125
22.75 10.644 31.25 10.375 39.75 10.117
23.00 10.636 31.50 10.367 40.00 10.110
23.25 10.628 31.75 10.360
: AMP may contain inhibitors for ALP. The manu-Note
facturers should declare that the buffer substance is suitable
for the investigation of ALP.
: The content of water in commercially availableNote
HEDTA differs. The percentage of water in the used lot shall
be documented in a certificate of analysis of the manufac-
turers and shall be taken into account by the preparation of
the metal ion buffer.
: The NPP reagent must meet the following criteriaNote
(declared in manufacturers’ certificate of analysis or con-
firmed by investigations of the user):
• Enzymatic conversion of NPP to 4-nitrophenol should
result in a hydrolysis of )0.98,
• The molar absorption coefficient of NPP at 311 nm in
sodium hydroxide, 10 mmol/L at 25 8C, should be
986.7 m2/mol"7.6 m2/mol,
• The mol fraction of 4-nitrophenol to NPP must be
-0.0003, and
• The mol fraction of inorganic phosphate to NPP must be
-0.01.
Detailed procedures for checking these conditions are given
by Bowers et al. (14).
Reagents of the highest purity must be used. If a chemical
is suspected of containing impurities affecting the catalytic
activity of the analyte further investigations must be per-
formed: e.g., comparisons with products from different man-
ufacturers and different lots.
It is recommended to use reagents which have already
been tested and approved in comparisons.
Charts for the adjustment and control of pH
Procedure for the adjustment of pH at temperatures
diverging from 37 8C
Both the thermometer and the pH electrode are suspended in
the mixed solution simultaneously. The stirred solution is
then titrated to the pH listed in the chart for the actually
measured temperature (Table 3). The speed of agitation
should be the same during the calibration and the control of
the pH-meter and the adjustment of the pH of the reagent
solutions. The pH electrode should be positioned in the cen-
ter of the stirred solution.
The possibility that the temperature can change during the
titration must be taken into account. For this reason, the tem-
perature in the proximity of the target value should be con-
trolled again and the target pH has to be corrected if
necessary. The same applies for the adjustment of the tem-
perature compensation of the pH meter.
Preparation of solutions
The given mass of the compounds for the preparation of
solutions refers to 100 % content. If the content of the rea-
gent chemical employed is less (e.g., yz %), the amount
equivalent to the given mass is calculated by the use of a
factor:
F s100/yzcontent
Highly purified water shall be used for the preparation of
the reagent solutions. Guidelines describing the preparation
and testing of reagent water are published elsewhere (15).
The expanded (ks2) combined uncertainty (normally dis-
tributed) of each weighing procedure (including the uncer-
tainty of the purity of the substance) shall be F1.5 %.
Solution 1
0.878 g (25.50 mmol/L) HEDTA; 0.367 g (12.75 mmol/L)
zinc sulfate; 0.547 g (25.50 mmol/L) magnesium acetate.
• Dissolve the HEDTA in approximately 70 mL water.
• Add the zinc sulfate to the solution.
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Table 4 Analytical system for the measurement of ALP.
2.000 mL reaction solution
Equilibrate to 37.0 8C
0.050 mL sample
Mix thoroughly and incubate for 60 s. At the end of the
incubation time, the temperature of the solution in the cuvette
shall have reached 37.0 8C
0.500 mL start reagent solution
Mix thoroughly, wait 90 s and monitor time and absorbance for
an additional 120 s
• Add the magnesium acetate only when the zinc sulfate is
completely dissolved.
• Dissolve the magnesium acetate in the solution.
• Transfer to a 100 mL volumetric flask.
• Equilibrate volumetric flask and water to 20 8C.
• Fill water up to the calibration mark of the volumetric
flask (20 8C).
Stability at 2–8 8C: 3 months.
Reaction solution
8.52 g (956.3 mmol/L) 2-Amino-2-methyl-1-propanol.
• Dissolve in approximately 70 mL water.
• Adjust pH (37 8C) 10.3 – pH (37 8C) 10.5 with 25 %
hydrochloric acid.
• Add 10 mL solution 1.
• Adjust pH (37 8C) 10.2 with hydrochloric acid (2 mol/L).
• Transfer to a 100 mL volumetric flask.
• Equilibrate volumetric flask and water to 20 8C.
• Fill water up to the calibration mark of the volumetric
flask (20 8C).
Stability at 2–8 8C: 3 months.
Start reagent solution
0.757 g (81.6 mmol/L) 4-Nitrophenyl phosphate, disodium
salt, hexahydrate.
• Dissolve in approximately 15 mL water.
• Transfer to a 25 mL volumetric flask.
• Equilibrate volumetric flask and water to 20 8C.
• Fill water up to the calibration mark of the volumetric
flask (20 8C).
Stability at 2–8 8C: 1 week.
Measurement procedure
Degas carefully the amount of reaction solution required for
the experiment. The degassing can be performed by using a
vacuum oven with a temperature set at 35 8C or warming
the solution up to approximately 35 8C following by storage
of it for 1 h in a vacuum desiccator while stirring with a
magnetic stirrer. If the degassed solution is not used within
the day, degas it again just before use.
Equilibrate only an adequate volume of start reagent solu-
tion at 37 8C in preparation for the measurement procedure.
The remaining volume of the start reagent solution should
be stored at 2–8 8C.
Pipette the volumes as listed in Table 4 one after another
into the cuvette.
Reagent blank rate
To determine the reagent blank rate, the specimen is replaced
by 9 g/L (154 mmol/L) sodium chloride solution. The meas-
urement procedure is then carried out as described above.
The reagent blank shows a non-linear kinetic. The accept-
able blank rate is positive and -3.0=10–5 s–1
(-0.0018 min–1).
: Due to the non-linearity of the kinetic, the reagentNote
blanks have a lower reproducibility. It is advisable to perform
at least three replicates and use the mean for further
calculations.
Sample blank rate
For the determination of the sample blank rate, the start rea-
gent solution is replaced by 9 g/L (154 mmol/L) sodium
chloride solution. The measurement procedure is then carried
out as described above.
: The sample blank rate is determined and docu-Note
mented, but not taken into account for calculation of the
catalytic concentration of ALP in control sera and calibra-
tors. In case of the value of the sample blank rate exceeding
1 % of total ALP, a warning that the respective material is
not appropriate for calibration should be issued.
: The reagent blank rate for the sample blank rate isNote
determined by replacing the start reagent solution and the
sample by 9 g/L (154 mmol/L) sodium chloride solution.
: Effects of the matrix of the sample on the indicatorNote
reaction have not been considered due to the omission of
NPP from the reaction mixture.
Upper limit of the measurement range
If the change of absorbance exceeds 0.0042 s–1 (0.25 min–1)
in the measurement interval, an analytical portion of the
sample must be diluted with 9 g/L (154 mmol/L) sodium
chloride solution and the measurement procedure must be
repeated with the diluted specimen (16). The obtained value
must then be multiplied by the corresponding factor of the
dilution.
: The following rules for the dilution of samples areNote
recommended for improved standardization.
The sample shall be diluted if the interval of the combined
expanded uncertainty and the upper limit of the measurement
range are overlapping. In this case pre-dilution of 10 volume
parts of the sample with one volume part of 9 g/L
(154 mmol/L) sodium chloride solution is recommended.
Adequate dilution shall be performed if the interval of the
combined expanded uncertainty is completely located above
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the upper limit of the measurement range. The change of
absorbance of the reaction mixture containing the pre-diluted
sample shall be in a range from 0.0034 s–1 (0.20 min–1) to
0.0038 s–1 (0.23 min–1)
Sources of error
• The temporal conversion rate is not linear for all samples.
The non-linearity depends on the matrix of the material
and the catalytic concentration of ALP. Deviations from
the described delay time and measurement time can lead
to non-commutability of the material and changed
method.
• The optimum pH in some control materials and calibra-
tors differs from the described pH of the reference pro-
cedure. This leads to an increased sensitivity to the
uncertainty of the pH adjustment.
• Absorbed carbon dioxide from the air changes the pH of
the reaction solution. Therefore, the container of reaction
solution shall be closed tightly. The pH in solution 1 shall
be controlled at least weekly.
• The catalytic concentration of ALP in some control mate-
rials increases during the storage. Such a material is not
suitable as a calibrator or as control material.
• A thorough mixing of the final complete reaction mixture
is necessary due to the high buffer concentration. Other-
wise the formation of streaks leads to a poor precision of
the measurement results.
Calculation
The temporal change of absorbance (s–1) is calculated with
analysis of regression (method of the least squares). After
subtraction of the reagent blank rate the corrected change of
absorbance is multiplied with the factor, Fs2729 (measure-
ment at 405 nm, ´405s1869 m2/mol).
: The use of the molar absorption coefficientNote
´405s1869 m2/mol is recommended by IFCC and IRMM.
The catalytic concentration of ALP is calculated in
mkat/L. DA/DtALP is the change of absorbance after correc-
tion of the reagent blank rate (in s–1); bALP is the catalytic
concentration of ALP (mkat/L); and bALPs2729 DA/DtALP.
The catalytic concentration in mkat/L can be converted to
U/L by multiplication by the factor fs60.
Preliminary reference values
• Females (18–49 years): 0.55–1.64 mkat/L; 33–98 U/L.
• Males (G20 years): 0.72–1.92 mkat/L; 43–115 U/L.
Details about the definition of the preliminary reference
values are given in Appendix II.
Appendix I
Changes in the IFCC reference procedure for
measurements at 37 8C compared with the reference
method for measurements at 30 8C as described in
the original IFCC document
The primary reference procedure is derived from the draft of
the IFCC reference method (2, 3), which provides optimized
conditions for the measurement of catalytic concentration of
ALP at 30 8C.
The measurement temperature of 37 8C instead of 30 8C
requires only minor changes of certain measurement para-
meters to retain the optimum measurement conditions. The
modifications are listed and commented on in this appendix.
Furthermore, if in comparison to the 30 8C reference method
a more accurate specification has become necessary for
improving the standardization of the measurements, it is also
described here in Table 5.
Appendix II
Determination of preliminary reference intervals
Sample collection was performed in four different European
centres: two sites in Milan (Italy) (Ospedale L. Sacco and
Ospedale S. Raffaele), one in Nancy (France) (Centre Med-
icine Preventive) and one in Bursa (Turkey) (Uludag Uni-
versity Medical School). The serum was collected using a
BD Vacutainer system (BD Becton, Dickinson and Compa-
ny) into plastic tubes with serum separator (SSTTM II). The
samples were allowed to clot at room temperature and cen-
trifuged (2000 g) within 1 h. Serum was separated and ali-
quoted within 4 h from blood collection. The aliquots were
frozen at –80 8C. The frozen aliquots were sent in dry ice
to the reference laboratory in Hannover where all the anal-
yses were performed. The reference analyses were performed
on a Konelab 30i instrument (Thermo Fisher Scientific). The
reagents were self-prepared according to the prescriptions in
this document. The measurement parameters and the meas-
urement design were configured as closely related as tech-
nically feasible. The calibration was performed by use of a
set of pooled sera with assigned target values for ALP
obtained by measurements using the manually performed
primary IFCC reference measurement procedure.
Subjects in Italy and Turkey were specifically enrolled for
the reference interval experiment and they gave informed
consent and replied to an ad hoc questionnaire; the samples
from France were left over samples from those collected for
a health screening program. All of the samples were obtained
from individuals in the fasting state. In addition to ALP, the
following tests were performed locally in all the samples:
aspartate aminotransferase (AST), alanine aminotransferase
(ALT), g-glutamyltransferase (GGT), glucose and creatinine;
in addition, total calcium and inorganic phosphate were
measured in the Hannover reference laboratory.
The ages of the enrolled subjects spanned from 5 to
87 years, but the number of subjects in the younger and older
age ranges was insufficient to provide reliable reference
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Table 5 Comparison of the IFCC methods for the measurement temperatures of 30 8C and 37 8C.
37 8C IFCC reference procedure 30 8C reference method Comment
Specimen of investigation
Calibration material, control Human sera The reference procedure will be used primarily for the measurement of
specimens and human sera control samples and calibration materials.
Uncertainty of the measurement temperature adjustment
Target uncertainty F0.1 8C (ks2) Bias: less "0.05 8C High quality spectro-photometer with devices for temperature
Imprecision: less "0.1 8C adjustment and control provide an uncertainty (ks2) of the
temperature F0.1 8C.
Incubation time
60 s No incubation time 60 s are necessary for mixing and closing the lid of the spectrometer.
Loss of temperature can be compensated in this time.
Delay time
90 s No information about The reagent blank rate is non-linear after the addition of the start reagent
the delay time solution. The non-linearity decreases with increasing delay time.
Measurement time
120 s Up to 300 s The reaction rate is not linear and the non-linearity proportionally
increases with the time and the catalytic concentration of ALP. Shorter
measurement time implies less non-linearity.
Concentration of AMP in the final complete reaction mixture
750 mmol/L 350 mmol/L 750 mmol/L AMP is the optimum buffer concentration. The pH value
of the buffer solution decreases faster with lower buffer concentrations.
The buffer solution is more stable with the increased AMP
concentration.
Start of the reaction
Solution R 2000 mL Solution R 2500 mL The reaction is started with serum in the 30 8C method and with
Serum 50 mL Serum 50 mL substrate in the 37 8C procedure.
Start solution 500 mL
Temperature of the start reagent solution before use
Start with substrate: the start Start with serum: no The use of start reagent solution with ambient temperature decreases the
reagent solution should be temperature equilibration temperature in the cuvette.
37 8C before use of the serum is described
Collection of data
Number of readings G6 Monitoring of the Modern spectrophotometers employ digital data processing. A number
increase in absorbance of readings G6 should ensure a sufficient precision of the measurement
results. Devices for a continuous monitoring are no longer in use.
Determination of the slope (time vs. absorbance)
Regression analysis of the No information A well-defined statistical method is necessary to ensure the
method of least squares reproducibility of the calculation of the slope.
Reference values
See Table 7 No reference values were The reference values for women and men were investigated separately.
given
Unit of catalytic enzymatic concentration
mkat/L and U/L mkat/L U/L is commonly used in clinical laboratory, but mkat/L is
based on the SI system.
Sample blank rate
Determined, but not taken Subtraction Usually, sample blank rates are not subtracted in routine procedures.
into account Therefore, assigned values in calibrators and control materials are
only useful for routine methods, if they include the sample blank
rate value.
intervals. Thus, results are presented only for adult pre-men-
opausal females and adult males. The origin of the partici-
pants and their age group distributions are shown in Table 6.
The population sizes from the different sites were similar,
but the Turkish group had a larger number of young subjects.
To exclude the possibility that any of the reference indi-
viduals were in late puberty, only individuals who were
18 years or older if females and 20 years or older if males
were included in the calculation. The decrease in ALP cat-
alytic activity to typical adult ranges is known to differ from
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Table 6 Age and origin of the enrolled subjects.
Age, Italy France Turkey Total
years (Milan) (Nancy) (Bursa)
Females 18–30 32 32 56 120
31–40 19 21 28 68
41–49 34 27 8 69
Total 85 80 92 257
Males 20–30 14 19 56 89
31–40 20 25 31 76
41–50 30 19 8 57
51–60 13 18 0 31
)60 7 6 0 13
Total 84 87 95 266
Table 7 ALP reference intervals.
Females, age 18–49 years Males, age G20 years
Number of subjects 257 266
2.58 percentile (90 % CI) 0.55 mkat/L (0.48–0.59) 0.72 mkat/L (0.65–0.76)
33 U/L (28.7–35.4) 43 U/L (39.2–45.8)
97.58 percentile (90 % CI) 1.64 mkat/L (1.50–1.73) 1.92 mkat/L (1.84–2.03)
98 U/L (89.8–103.6) 115 U/L (110.1–121.6)
subject to subject and occurs on average 2 years earlier in
females than in males.
Moreover, as for females a progressive increase of both
lower and upper reference limit following the menopause is
described (17), we excluded females older than 49 years. As
for males no age-related increase in ALP has been described,
all the data, including those from elderly people, were
included in the calculation.
Exclusion criteria
Participants were excluded from the study if suffering for
diabetes (glucose )7.0 mmol/L), renal impairment wcreati-
nine )115 mmol/L if females, 133 mmol/L if malesx, liver
damage (AST, ALT or GGT )100 U/L), total calcium and
inorganic phosphate outside the reference intervals (2.15–
2.60 mmol/L and 0.80–1.50 mmol/L, respectively).
ALP results
The results of adult males and adult pre-menopausal females
were compared using the approach proposed by Lahti et al.
(18, 19) and partitioning was suggested, so the two groups
were considered separately.
Results for women from the three collection sites were
compared using the Lahti et al. (18, 19) statistical method
and the Turkish group was found to be significantly different
from the French group, whereas difference with the Italian
group was only marginal; the Italian and French groups were
significantly different only at the lower reference limit.
Hence, statistically the three groups were different; however,
because the Turkish group was significantly younger and the
lower reference limit is clinically less relevant, all the data
were merged. The differences among the results from men
across the three sites were less pronounced than those of the
women. The application of the Lahti algorithm indicated
only marginal differences.
The reference limits, calculated with the non-parametric
approach, are reported in Table 7.
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